New NavaX-powered capabilities combine Dynamic Data Extraction, Translation, Conversational AI, and Intelligent Follow-up Management to modernize adverse event, medical information and product quality complaints reporting.
Strategic partnership with TransPerfect Life Sciences embeds certified, pharma-grade translation directly into LifeSphere Safety ...
XDI brings the first federated solution for life sciences, collapsing data silos, unifying meaning, and ...
MADRID, SPAIN – February 11, 2026 – ArisGlobal, an AI-first technology company at ...
The Ukrainian pharmaceutical company modernizes regulatory operations with a centralized platform and multi-phase innovation strategy.
The latest deployment further highlights the momentum around production AI-driven NavaX implementations, and showcases the platform’s readiness for complex, character-based languages.
More than 100 new and expanded LifeSphere customers, 34 global go-lives, and rapid enterprise adoption of NavaX signal strong momentum
More than 50 executive speakers and 300 life sciences professionals ...
Company leverages Generative AI across case management processes, achieving ...
Orchestrated by the NavaX Super Agent, the Suite includes previously ...
ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.
Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.
Quick Links
© 2026 ArisGlobal – All Rights Reserved
